Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

Roche meldde in een verklaring dat deze initiële investering in de toekomst mogelijk wordt uitgebreid, afhankelijk van de zakelijke behoeften en het Amerikaanse beleidsklimaat. De verwachting is dat ...

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

Swiss pharmaceutical and diagnostics giant Roche pledged on Monday to inject at least $700 million into the construction of a new plant in the United States.

Roche and Genentech to spend $700 million building new manufacturing facility May 12, 2025 by Mai Tao Genentech , a ...